Tapewire

NYSE · USD

VTR

Ventas, Inc.

Export transactions ↓
Tapewire entity
3044
SEC CIK
0000740260
Parsed reports
885

Last 12 months

Inside the activity.

1 purchase rows · 20 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025013
Dec 202501
Jan 202602
Feb 202603
Mar 202600
Apr 202600
May 202601
Jun 202610
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
November 03, 2025 Filed Nov 3, 2025 23:56 UTC
CAFARO DEBRA ADirector · Chairman and CEO
SaleCommon Stock 10,322 $73.98 $763,594.72
Disclosure

SEC source: 0001215188-25-000008 · wk-form4_1762214203.xml · nonDerivative · entry 10

CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,145,695

F3 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 10 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024.

F9 · price: The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $73.86 to $74.1829, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
November 03, 2025 Filed Nov 3, 2025 23:56 UTC
CAFARO DEBRA ADirector · Chairman and CEO
Exercise / conversionCommon Stock 10,322 $73.71 $760,834.62
Disclosure

SEC source: 0001215188-25-000008 · wk-form4_1762214203.xml · nonDerivative · entry 9

CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,156,017

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 10 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024.

Read SEC document
October 30, 2025 Filed Nov 3, 2025 23:56 UTC
CAFARO DEBRA ADirector · Chairman and CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 224,360 $0.00 Strike: $62.22 $0.00
Disclosure

SEC source: 0001215188-25-000008 · wk-form4_1762214203.xml · derivative · entry 16

CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 134,192

Underlying: Common Stock · 224,360 shares

Expires 2027-01-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 15 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024.

F11 · derivative.exercise_date: Fully vested.

F12 · balance_after: Represents total number of unexercised options to purchase shares of Issuer's Common Stock held by the Reporting Person.

Read SEC document
October 30, 2025 Filed Nov 3, 2025 23:56 UTC
CAFARO DEBRA ADirector · Chairman and CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 41,288 $0.00 Strike: $63.24 $0.00
Disclosure

SEC source: 0001215188-25-000008 · wk-form4_1762214203.xml · derivative · entry 15

CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 358,552

Underlying: Common Stock · 41,288 shares

Expires 2026-11-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 13 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024.

F11 · derivative.exercise_date: Fully vested.

F12 · balance_after: Represents total number of unexercised options to purchase shares of Issuer's Common Stock held by the Reporting Person.

Read SEC document
October 30, 2025 Filed Nov 3, 2025 23:56 UTC
CAFARO DEBRA ADirector · Chairman and CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 30,966 $0.00 Strike: $73.71 $0.00
Disclosure

SEC source: 0001215188-25-000008 · wk-form4_1762214203.xml · derivative · entry 14

CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 399,840

Underlying: Common Stock · 30,966 shares

Expires 2026-08-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 10 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024.

F11 · derivative.exercise_date: Fully vested.

F12 · balance_after: Represents total number of unexercised options to purchase shares of Issuer's Common Stock held by the Reporting Person.

Read SEC document
October 30, 2025 Filed Nov 3, 2025 23:56 UTC
CAFARO DEBRA ADirector · Chairman and CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 20,644 $0.00 Strike: $65.45 $0.00
Disclosure

SEC source: 0001215188-25-000008 · wk-form4_1762214203.xml · derivative · entry 13

CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 430,806

Underlying: Common Stock · 20,644 shares

Expires 2026-05-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 7 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024.

F11 · derivative.exercise_date: Fully vested.

F12 · balance_after: Represents total number of unexercised options to purchase shares of Issuer's Common Stock held by the Reporting Person.

Read SEC document
October 30, 2025 Filed Nov 3, 2025 23:56 UTC
CAFARO DEBRA ADirector · Chairman and CEO
SaleCommon Stock 224,360 $74.34 $16,678,383.94
Disclosure

SEC source: 0001215188-25-000008 · wk-form4_1762214203.xml · nonDerivative · entry 8

CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,145,695

F7 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 15 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024.

F8 · price: The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $74.00 to $74.68, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
October 30, 2025 Filed Nov 3, 2025 23:56 UTC
CAFARO DEBRA ADirector · Chairman and CEO
Exercise / conversionCommon Stock 224,360 $62.22 $13,959,679.20
Disclosure

SEC source: 0001215188-25-000008 · wk-form4_1762214203.xml · nonDerivative · entry 7

CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,370,055

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 15 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024.

Read SEC document
October 30, 2025 Filed Nov 3, 2025 23:56 UTC
CAFARO DEBRA ADirector · Chairman and CEO
SaleCommon Stock 41,288 $73.64 $3,040,345.10
Disclosure

SEC source: 0001215188-25-000008 · wk-form4_1762214203.xml · nonDerivative · entry 6

CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,145,695

F5 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 13 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024.

F6 · price: The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $72.05 to $74.71, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
October 30, 2025 Filed Nov 3, 2025 23:56 UTC
CAFARO DEBRA ADirector · Chairman and CEO
Exercise / conversionCommon Stock 41,288 $63.24 $2,611,053.12
Disclosure

SEC source: 0001215188-25-000008 · wk-form4_1762214203.xml · nonDerivative · entry 5

CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,186,983

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 13 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024.

Read SEC document
October 30, 2025 Filed Nov 3, 2025 23:56 UTC
CAFARO DEBRA ADirector · Chairman and CEO
SaleCommon Stock 30,966 $74.32 $2,301,318.80
Disclosure

SEC source: 0001215188-25-000008 · wk-form4_1762214203.xml · nonDerivative · entry 4

CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,145,695

F3 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 10 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024.

F4 · price: The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $73.87 to $74.68, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
October 30, 2025 Filed Nov 3, 2025 23:56 UTC
CAFARO DEBRA ADirector · Chairman and CEO
Exercise / conversionCommon Stock 30,966 $73.71 $2,282,503.86
Disclosure

SEC source: 0001215188-25-000008 · wk-form4_1762214203.xml · nonDerivative · entry 3

CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,176,661

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 10 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024.

Read SEC document
October 30, 2025 Filed Nov 3, 2025 23:56 UTC
CAFARO DEBRA ADirector · Chairman and CEO
SaleCommon Stock 20,644 $74.34 $1,534,720.38
Disclosure

SEC source: 0001215188-25-000008 · wk-form4_1762214203.xml · nonDerivative · entry 2

CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,145,695

F1 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 7 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024.

F2 · price: The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $74.00 to $74.66, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
October 30, 2025 Filed Nov 3, 2025 23:56 UTC
CAFARO DEBRA ADirector · Chairman and CEO
Exercise / conversionCommon Stock 20,644 $65.45 $1,351,149.80
Disclosure

SEC source: 0001215188-25-000008 · wk-form4_1762214203.xml · nonDerivative · entry 1

CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,166,339

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 7 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024.

Read SEC document
October 20, 2025 Filed Oct 22, 2025 22:47 UTC
CAFARO DEBRA ADirector · Chairman and CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 34,232 $0.00 Strike: $65.45 $0.00
Disclosure

SEC source: 0001215188-25-000006 · wk-form4_1761173256.xml · derivative · entry 6

CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 451,450

Underlying: Common Stock · 34,232 shares

Expires 2026-05-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 7 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024.

F4 · derivative.exercise_date: Fully vested.

F5 · balance_after: Represents total number of unexercised options to purchase shares of Issuer's Common Stock held by the Reporting Person.

Read SEC document
October 20, 2025 Filed Oct 22, 2025 22:47 UTC
CAFARO DEBRA ADirector · Chairman and CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 185,283 $0.00 Strike: $62.22 $0.00
Disclosure

SEC source: 0001215188-25-000006 · wk-form4_1761173256.xml · derivative · entry 5

CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 485,682

Underlying: Common Stock · 185,283 shares

Expires 2027-01-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 15 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024.

F4 · derivative.exercise_date: Fully vested.

F5 · balance_after: Represents total number of unexercised options to purchase shares of Issuer's Common Stock held by the Reporting Person.

Read SEC document
October 20, 2025 Filed Oct 22, 2025 22:47 UTC
CAFARO DEBRA ADirector · Chairman and CEO
SaleCommon Stock 34,232 $71.32 $2,441,518.67
Disclosure

SEC source: 0001215188-25-000006 · wk-form4_1761173256.xml · nonDerivative · entry 4

CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,145,695

F3 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 7 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024.

F2 · price: The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $71.00 to $71.50, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
October 20, 2025 Filed Oct 22, 2025 22:47 UTC
CAFARO DEBRA ADirector · Chairman and CEO
Exercise / conversionCommon Stock 34,232 $65.45 $2,240,484.40
Disclosure

SEC source: 0001215188-25-000006 · wk-form4_1761173256.xml · nonDerivative · entry 3

CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,179,927

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 7 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024.

Read SEC document
October 20, 2025 Filed Oct 22, 2025 22:47 UTC
CAFARO DEBRA ADirector · Chairman and CEO
SaleCommon Stock 185,283 $71.32 $13,214,883.82
Disclosure

SEC source: 0001215188-25-000006 · wk-form4_1761173256.xml · nonDerivative · entry 2

CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,145,695

F1 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 15 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024.

F2 · price: The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $71.00 to $71.50, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
October 20, 2025 Filed Oct 22, 2025 22:47 UTC
CAFARO DEBRA ADirector · Chairman and CEO
Exercise / conversionCommon Stock 185,283 $62.22 $11,528,308.26
Disclosure

SEC source: 0001215188-25-000006 · wk-form4_1761173256.xml · nonDerivative · entry 1

CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,330,978

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 15 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024.

Read SEC document
October 16, 2025 Filed Oct 16, 2025 22:45 UTC GrantCommon Stock 74.76 $69.55 $5,199.56
Disclosure

SEC source: 0000740260-25-000271 · wk-form4_1760654740.xml · nonDerivative · entry 2

Smith Maurice S · CIK 0001841752 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,481.871

F3 · shares: Common stock in the form of units granted under the Ventas, Inc. Non-Employee Directors' Equity Award Deferral Program (the "Program") adopted pursuant to the Ventas, Inc. 2022 Incentive Plan as a result of dividend equivalents credited with respect to the dividend on Issuer's common stock paid on October 16, 2025. Such units are payable solely in common stock and subject to the terms and conditions of the Reporting Person's deferral election and the Program.

F2 · price: Represents the closing price per share of Issuer's common stock as of the grant date.

Read SEC document
October 16, 2025 Filed Oct 16, 2025 22:45 UTC GrantCommon Stock 59.484 $69.55 $4,137.11
Disclosure

SEC source: 0000740260-25-000271 · wk-form4_1760654740.xml · nonDerivative · entry 1

Smith Maurice S · CIK 0001841752 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,407.111

F1 · shares: Common stock in the form of units granted under the Ventas, Inc. Non-Employee Directors' Cash Compensation Deferral Plan (the "Plan") as a result of dividend equivalents credited with respect to the dividend on Issuer's common stock paid on October 16, 2025. Such units are payable solely in common stock and subject to the terms and conditions of the Reporting Person's deferral election and the Plan.

F2 · price: Represents the closing price per share of Issuer's common stock as of the grant date.

Read SEC document
October 16, 2025 Filed Oct 16, 2025 22:45 UTC
Roy SumitDirector
GrantCommon Stock 74.76 $69.55 $5,199.56
Disclosure

SEC source: 0000740260-25-000270 · wk-form4_1760654736.xml · nonDerivative · entry 2

Roy Sumit · CIK 0001529329 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,339.344

F3 · shares: Common stock in the form of units granted under the Ventas, Inc. Non-Employee Directors' Equity Award Deferral Program (the "Program") adopted pursuant to the Ventas, Inc. 2022 Incentive Plan as a result of dividend equivalents credited with respect to the dividend on Issuer's common stock paid on October 16, 2025. Such units are payable solely in common stock and subject to the terms and conditions of the Reporting Person's deferral election and the Program.

F2 · price: Represents the closing price per share of Issuer's common stock as of the grant date.

Read SEC document
October 16, 2025 Filed Oct 16, 2025 22:45 UTC
Roy SumitDirector
GrantCommon Stock 49.89 $69.55 $3,469.85
Disclosure

SEC source: 0000740260-25-000270 · wk-form4_1760654736.xml · nonDerivative · entry 1

Roy Sumit · CIK 0001529329 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,264.584

F1 · shares: Common stock in the form of units granted under the Ventas, Inc. Non-Employee Directors' Cash Compensation Deferral Plan (the "Plan") as a result of dividend equivalents credited with respect to the dividend on Issuer's common stock paid on October 16, 2025. Such units are payable solely in common stock and subject to the terms and conditions of the Reporting Person's deferral election and the Plan.

F2 · price: Represents the closing price per share of Issuer's common stock as of the grant date.

Read SEC document
October 16, 2025 Filed Oct 16, 2025 22:45 UTC GrantCommon Stock 46.173 $69.55 $3,211.33
Disclosure

SEC source: 0000740260-25-000269 · wk-form4_1760654731.xml · nonDerivative · entry 1

Rodriguez Joe Vasquez Jr. · CIK 0002014328 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,764.461

F1 · shares: Common stock in the form of units granted under the Ventas, Inc. Non-Employee Directors' Equity Award Deferral Program (the "Program") adopted pursuant to the Ventas, Inc. 2022 Incentive Plan as a result of dividend equivalents credited with respect to the dividend on Issuer's common stock paid on October 16, 2025. Such units are payable solely in common stock and subject to the terms and conditions of the Reporting Person's deferral election and the Program.

F2 · price: Represents the closing price per share of Issuer's common stock as of the grant date.

Read SEC document
October 16, 2025 Filed Oct 16, 2025 22:45 UTC GrantCommon Stock 74.76 $69.55 $5,199.56
Disclosure

SEC source: 0001356681-25-000007 · wk-form4_1760654726.xml · nonDerivative · entry 1

NADER MARGUERITE M · CIK 0001356681 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,290.153

F1 · shares: Common stock in the form of units granted under the Ventas, Inc. Non-Employee Directors' Equity Award Deferral Program (the "Program") adopted pursuant to the Ventas, Inc. 2022 Incentive Plan as a result of dividend equivalents credited with respect to the dividend on Issuer's common stock paid on October 16, 2025. Such units are payable solely in common stock and subject to the terms and conditions of the Reporting Person's deferral election and the Program.

F2 · price: Represents the closing price per share of Issuer's common stock as of the grant date.

Read SEC document
October 16, 2025 Filed Oct 16, 2025 22:45 UTC GrantCommon Stock 201.433 $69.55 $14,009.67
Disclosure

SEC source: 0000740260-25-000268 · wk-form4_1760654722.xml · nonDerivative · entry 1

Martino Roxanne M · CIK 0001676558 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,417.095

F1 · shares: Common stock in the form of units granted under the Ventas, Inc. Non-Employee Directors' Cash Compensation Deferral Plan (the "Plan") as a result of dividend equivalents credited with respect to the dividend on Issuer's common stock paid on October 16, 2025. Such units are payable solely in common stock and subject to the terms and conditions of the Reporting Person's deferral election and the Plan.

F2 · price: Represents the closing price per share of Issuer's common stock as of the grant date.

Read SEC document
October 16, 2025 Filed Oct 16, 2025 22:45 UTC GrantCommon Stock 74.76 $69.55 $5,199.56
Disclosure

SEC source: 0000740260-25-000267 · wk-form4_1760654717.xml · nonDerivative · entry 2

LUSTIG MATTHEW J · CIK 0001203367 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 91,546.943

F3 · shares: Common stock in the form of units granted under the Ventas, Inc. Non-Employee Directors' Equity Award Deferral Program (the "Program") adopted pursuant to the Ventas, Inc. 2022 Incentive Plan as a result of dividend equivalents credited with respect to the dividend on Issuer's common stock paid on October 16, 2025. Such units are payable solely in common stock and subject to the terms and conditions of the Reporting Person's deferral election and the Program.

F2 · price: Represents the closing price per share of Issuer's common stock as of the grant date.

Read SEC document
October 16, 2025 Filed Oct 16, 2025 22:45 UTC GrantCommon Stock 250.738 $69.55 $17,438.83
Disclosure

SEC source: 0000740260-25-000267 · wk-form4_1760654717.xml · nonDerivative · entry 1

LUSTIG MATTHEW J · CIK 0001203367 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 91,472.183

F1 · shares: Common stock in the form of units granted under the Ventas, Inc. Non-Employee Directors' Cash Compensation Deferral Plan (the "Plan") as a result of dividend equivalents credited with respect to the dividend on Issuer's common stock paid on October 16, 2025. Such units are payable solely in common stock and subject to the terms and conditions of the Reporting Person's deferral election and the Plan.

F2 · price: Represents the closing price per share of Issuer's common stock as of the grant date.

Read SEC document
October 16, 2025 Filed Oct 16, 2025 22:45 UTC GrantCommon Stock 74.76 $69.55 $5,199.56
Disclosure

SEC source: 0000740260-25-000266 · wk-form4_1760654713.xml · nonDerivative · entry 1

EMBLER MICHAEL J · CIK 0001209170 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,520.153

F1 · shares: Common stock in the form of units granted under the Ventas, Inc. Non-Employee Directors' Equity Award Deferral Program (the "Program") adopted pursuant to the Ventas, Inc. 2022 Incentive Plan as a result of dividend equivalents credited with respect to the dividend on Issuer's common stock paid on October 16, 2025. Such units are payable solely in common stock and subject to the terms and conditions of the Reporting Person's deferral election and the Program.

F2 · price: Represents the closing price per share of Issuer's common stock as of the grant date.

Read SEC document
October 16, 2025 Filed Oct 16, 2025 22:45 UTC GrantCommon Stock 74.76 $69.55 $5,199.56
Disclosure

SEC source: 0000740260-25-000265 · wk-form4_1760654709.xml · nonDerivative · entry 1

Barnes Melody C · CIK 0001619369 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,125.153

F1 · shares: Common stock in the form of units granted under the Ventas, Inc. Non-Employee Directors' Equity Award Deferral Program (the "Program") adopted pursuant to the Ventas, Inc. 2022 Incentive Plan as a result of dividend equivalents credited with respect to the dividend on Issuer's common stock paid on October 16, 2025. Such units are payable solely in common stock and subject to the terms and conditions of the Reporting Person's deferral election and the Program.

F2 · price: Represents the closing price per share of Issuer's common stock as of the grant date.

Read SEC document
October 01, 2025 Filed Oct 2, 2025 21:46 UTC GrantCommon Stock 533.276 $70.32 $37,499.97
Disclosure

SEC source: 0000740260-25-000256 · wk-form4_1759441571.xml · nonDerivative · entry 1

Smith Maurice S · CIK 0001841752 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,347.627

F1 · shares: Common stock in the form of units granted under the Ventas, Inc. Non-Employee Directors' Cash Compensation Deferral Plan (the "Plan") in lieu of director fees pursuant to the director's deferral election. Such units are payable solely in common stock and subject to the terms and conditions of the director's deferral election and the Plan.

F2 · price: Represents the closing price per share of Issuer's common stock as of the grant date.

Read SEC document
October 01, 2025 Filed Oct 2, 2025 21:46 UTC
Roy SumitDirector
GrantCommon Stock 444.397 $70.32 $31,250.00
Disclosure

SEC source: 0000740260-25-000255 · wk-form4_1759441559.xml · nonDerivative · entry 1

Roy Sumit · CIK 0001529329 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,214.694

F1 · shares: Common stock in the form of units granted under the Ventas, Inc. Non-Employee Directors' Cash Compensation Deferral Plan (the "Plan") in lieu of director fees pursuant to the director's deferral election. Such units are payable solely in common stock and subject to the terms and conditions of the director's deferral election and the Plan.

F2 · price: Represents the closing price per share of Issuer's common stock as of the grant date.

Read SEC document
October 01, 2025 Filed Oct 2, 2025 21:45 UTC GrantCommon Stock 728.811 $70.32 $51,249.99
Disclosure

SEC source: 0000740260-25-000254 · wk-form4_1759441546.xml · nonDerivative · entry 1

Martino Roxanne M · CIK 0001676558 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,215.662

F1 · shares: Common stock in the form of units granted under the Ventas, Inc. Non-Employee Directors' Cash Compensation Deferral Plan (the "Plan") in lieu of director fees pursuant to the director's deferral election. Such units are payable solely in common stock and subject to the terms and conditions of the director's deferral election and the Plan.

F2 · price: Represents the closing price per share of Issuer's common stock as of the grant date.

Read SEC document
October 01, 2025 Filed Oct 2, 2025 21:45 UTC GrantCommon Stock 462.173 $70.32 $32,500.01
Disclosure

SEC source: 0000740260-25-000253 · wk-form4_1759441536.xml · nonDerivative · entry 1

LUSTIG MATTHEW J · CIK 0001203367 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 91,221.445

F1 · shares: Common stock in the form of units granted under the Ventas, Inc. Non-Employee Directors' Cash Compensation Deferral Plan (the "Plan") in lieu of director fees pursuant to the director's deferral election. Such units are payable solely in common stock and subject to the terms and conditions of the director's deferral election and the Plan.

F2 · price: Represents the closing price per share of Issuer's common stock as of the grant date.

Read SEC document
October 01, 2025 Filed Oct 2, 2025 21:45 UTC
CAFARO DEBRA ADirector · Chairman and CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 10,322 $0.00 Strike: $65.45 $0.00
Disclosure

SEC source: 0000740260-25-000252 · wk-form4_1759441523.xml · derivative · entry 3

CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 670,965

Underlying: Common Stock · 10,322 shares

Expires 2026-05-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Fully vested.

F4 · balance_after: Represents total number of unexercised options to purchase shares of Issuer's Common Stock held by the Reporting Person.

Read SEC document
October 01, 2025 Filed Oct 2, 2025 21:45 UTC
CAFARO DEBRA ADirector · Chairman and CEO
SaleCommon Stock 10,322 $70.24 $724,986.31
Disclosure

SEC source: 0000740260-25-000252 · wk-form4_1759441523.xml · nonDerivative · entry 2

CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,145,695

F1 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 8 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024.

F2 · price: The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $69.8327 to $70.472, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
October 01, 2025 Filed Oct 2, 2025 21:45 UTC
CAFARO DEBRA ADirector · Chairman and CEO
Exercise / conversionCommon Stock 10,322 $65.45 $675,574.90
Disclosure

SEC source: 0000740260-25-000252 · wk-form4_1759441523.xml · nonDerivative · entry 1

CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,156,017

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 8 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024.

Read SEC document
October 01, 2025 Filed Oct 2, 2025 21:45 UTC
Bulgarelli Peter J.EVP OM&R-Ventas/Pres&CEO-LHS
SaleCommon Stock 2,554 $70.26 $179,435.36
Disclosure

SEC source: 0000740260-25-000251 · wk-form4_1759441516.xml · nonDerivative · entry 2

Bulgarelli Peter J. · CIK 0001736887 · EVP OM&R-Ventas/Pres&CEO-LHS

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 116,488

F1 · shares: Transaction is pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on February 20, 2025.

F2 · price: The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $69.9931 to $70.4706, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
September 30, 2025 Filed Oct 2, 2025 21:45 UTC
Bulgarelli Peter J.EVP OM&R-Ventas/Pres&CEO-LHS
SaleCommon Stock 2,040 $69.99 $142,779.60
Disclosure

SEC source: 0000740260-25-000251 · wk-form4_1759441516.xml · nonDerivative · entry 1

Bulgarelli Peter J. · CIK 0001736887 · EVP OM&R-Ventas/Pres&CEO-LHS

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 119,042

F1 · shares: Transaction is pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on February 20, 2025.

Read SEC document
September 15, 2025 Filed Sep 17, 2025 21:51 UTC
Bulgarelli Peter J.EVP OM&R-Ventas/Pres&CEO-LHS
SaleCommon Stock 406 $70.00 $28,418.94
Disclosure

SEC source: 0000740260-25-000240 · wk-form4_1758145865.xml · nonDerivative · entry 1

Bulgarelli Peter J. · CIK 0001736887 · EVP OM&R-Ventas/Pres&CEO-LHS

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 121,082

F1 · shares: Transaction is pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on February 20, 2025.

F2 · price: The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $69.99 to $70.00, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
September 02, 2025 Filed Sep 4, 2025 22:03 UTC
CAFARO DEBRA ADirector · Chairman and CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 10,322 $0.00 Strike: $65.45 $0.00
Disclosure

SEC source: 0001215188-25-000004 · wk-form4_1757023426.xml · derivative · entry 3

CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 681,287

Underlying: Common Stock · 10,322 shares

Expires 2026-05-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Fully vested.

F4 · balance_after: Represents total number of unexercised options to purchase shares of Issuer's Common Stock held by the Reporting Person.

Read SEC document
September 02, 2025 Filed Sep 4, 2025 22:03 UTC
CAFARO DEBRA ADirector · Chairman and CEO
SaleCommon Stock 10,322 $67.80 $699,863.60
Disclosure

SEC source: 0001215188-25-000004 · wk-form4_1757023426.xml · nonDerivative · entry 2

CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,145,695

F1 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 9 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024.

F2 · price: The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $67.4096 to $68.12, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
September 02, 2025 Filed Sep 4, 2025 22:03 UTC
CAFARO DEBRA ADirector · Chairman and CEO
Exercise / conversionCommon Stock 10,322 $65.45 $675,574.90
Disclosure

SEC source: 0001215188-25-000004 · wk-form4_1757023426.xml · nonDerivative · entry 1

CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,156,017

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 9 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024.

Read SEC document
August 04, 2025 Filed Aug 6, 2025 20:54 UTC
Probst Robert FEVP and CFO
Exercise / conversionStock Option (Right to Buy) · Derivative 29,691 $0.00 Strike: $65.45 $0.00
Disclosure

SEC source: 0000740260-25-000237 · wk-form4_1754513678.xml · derivative · entry 3

Probst Robert F · CIK 0001531510 · EVP and CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 33,591

Underlying: Common Stock · 29,691 shares

Expires 2026-05-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Fully vested.

F4 · balance_after: Represents total number of unexercised options to purchase shares of Issuer's Common Stock held by the Reporting Person.

Read SEC document
August 04, 2025 Filed Aug 6, 2025 20:54 UTC
Probst Robert FEVP and CFO
SaleCommon Stock 29,691 $68.49 $2,033,587.06
Disclosure

SEC source: 0000740260-25-000237 · wk-form4_1754513678.xml · nonDerivative · entry 2

Probst Robert F · CIK 0001531510 · EVP and CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 168,364

F1 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 9 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on February 19, 2025.

F2 · price: The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $68.45 to $68.5563, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
August 04, 2025 Filed Aug 6, 2025 20:54 UTC
Probst Robert FEVP and CFO
Exercise / conversionCommon Stock 29,691 $65.45 $1,943,275.95
Disclosure

SEC source: 0000740260-25-000237 · wk-form4_1754513678.xml · nonDerivative · entry 1

Probst Robert F · CIK 0001531510 · EVP and CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 198,055

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 9 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on February 19, 2025.

Read SEC document
August 01, 2025 Filed Aug 1, 2025 22:31 UTC
CAFARO DEBRA ADirector · Chairman and CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 10,322 $0.00 Strike: $65.45 $0.00
Disclosure

SEC source: 0000740260-25-000235 · wk-form4_1754087489.xml · derivative · entry 3

CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 691,609

Underlying: Common Stock · 10,322 shares

Expires 2026-05-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Fully vested.

F4 · balance_after: Represents total number of unexercised options to purchase shares of Issuer's Common Stock held by the Reporting Person.

Read SEC document
August 01, 2025 Filed Aug 1, 2025 22:31 UTC
CAFARO DEBRA ADirector · Chairman and CEO
SaleCommon Stock 10,322 $67.40 $695,722.41
Disclosure

SEC source: 0000740260-25-000235 · wk-form4_1754087489.xml · nonDerivative · entry 2

CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,145,695

F1 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 10 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024.

F2 · price: The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $66.67 to $67.85, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
August 01, 2025 Filed Aug 1, 2025 22:31 UTC
CAFARO DEBRA ADirector · Chairman and CEO
Exercise / conversionCommon Stock 10,322 $65.45 $675,574.90
Disclosure

SEC source: 0000740260-25-000235 · wk-form4_1754087489.xml · nonDerivative · entry 1

CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,156,017

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 10 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.